We are thrilled to be contributing to the next generation of music industry leaders”— John Harris TORONTO, ON, CANADA, ...
The novel oral selective estrogen receptor (ER) degrader giredestrant significantly reduced the risk of invasive disease ...
In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...
Idaho universities and the Boise VA launch a five-year NIH-backed Healthy Idaho CTR-D program to translate research into practical health care solutions statewide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results